Novartis cancer researchers advance precision medicine
نویسندگان
چکیده
Genoptix, a Novartis molecular diagnostics company in Carlsbad, CA, introduced the nextgeneration sequencing-based test with the help of the Cambridge researchers for diagnosing non-small cell lung cancer. Marking more progress toward precision medicine in cancer, the test uses information from an individual’s sequenced tumor genes to pinpoint mutations that tip off experts that a patient might benefit from specific targeted drugs.
منابع مشابه
Clinical Cancer Advances 2018: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology.
A MESSAGE FROM ASCO'S PRESIDENT I remember when ASCO first conceived of publishing an annual report on the most transformative research occurring in cancer care. Thirteen reports later, the progress we have chronicled is remarkable, and this year is no different. The research featured in ASCO's Clinical Cancer Advances 2018 report underscores the impressive gains in our understanding of cancer ...
متن کاملThe 21st Annual Prostate Cancer Foundation Scientific Retreat report.
The 21st Annual Prostate Cancer Foundation (PCF) Scientific Retreat was held from October 23-25, 2014, in Carlsbad, CA. This event is the world's foremost scientific meeting focusing on prostate cancer and brings together leading basic, translational and clinical researchers in prostate cancer and other diverse disciplines to discuss the newest findings most likely to advance the understanding ...
متن کاملThe 2010 Health Care Reform Act: a potential opportunity to advance cancer research by taking cancer personally.
The Patient Protection and Affordable Care Act of 2010 will have a profound influence on health care in the United States, including how we conduct cancer research and cancer care delivery. For this reason, oncologists and researchers must be intimately involved in the implementation and interpretation of this important legislation. A major goal of the Act is to improve access to affordable, qu...
متن کاملCancer Cell Line Encyclopedia launched by Novartis and Broad Institute.
The information included in the encyclopedia may help researchers identify those patients who could benefit from specific drugs; the researchers involved in the cataloging of these data suggest that cell-line collection such as this could enable a successful preclinical stratification schemata for anticancer agents. It is hoped that the emergence of personalized therapies could be assisted by t...
متن کاملAdvances in Text Mining and Visualization for Precision Medicine.
According to the National Institutes of Health (NIH), precision medicine is "an emerging approach for disease treatment and prevention that takes into account individual variability in genes, environment, and lifestyle for each person." Although the text mining community has explored this realm for some years, the official endorsement and funding launched in 2015 with the Precision Medicine Ini...
متن کامل